- Merck plans to acquire Acceleron Pharma for about $11.5 billion to expand its rare disease drug portfolio.
- Sanofi will acquire New York City-based drugmaker Kadmon for $1.9 billion.
- Pfizer entered into a definitive agreement to buy Canadian cancer drugmaker Trillium Therapeutics for $2.26 billion.
- Bayer has acquired San Diego-based biotech Vividion Therapeutics for $1.5 billion up front, with $500 million in potential success-based milestone payments.
- Sanofi will acquire clinical-stage mRNA therapeutics company Translate Bio for $3.2 billion.
- PerkinElmer is buying antibody and reagents maker BioLegend in a $5.25 billion deal.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
